UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

The New England journal of medicine, 2022-01, Vol.386 (4), p.351-363

2022

Volltextzugriff (PDF)

The effect of types of sensory feedback on the acquisition and retention of squat performance: A randomized, double‐blind, controlled trial

Scandinavian journal of medicine & science in sports, 2024-01, Vol.34 (1), p.e14531-n/a

2024

Volltextzugriff (PDF)

Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma

Cancer science, 2013-12, Vol.104 (12), p.1656-1661

2013

Volltextzugriff (PDF)

The impact of smartphone use on gait in young adults: Cognitive load vs posture of texting

PloS one, 2020-10, Vol.15 (10), p.e0240118-e0240118

2020

Volltextzugriff (PDF)

Safety, pharmacokinetics, and pharmacodynamics of a next‐generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients

Journal of thrombosis and haemostasis, 2021-04, Vol.19 (4), p.967-975

2021

Volltextzugriff (PDF)

BAY 94‐9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-11, Vol.25 (6), p.1011-1019

2019

Volltextzugriff (PDF)

Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)

British journal of haematology, 2020-04, Vol.189 (2), p.303-312

2020

Volltextzugriff (PDF)

Influence of Loads and Loading Position on the Muscle Activity of the Trunk and Lower Extremity during Squat Exercise

International journal of environmental research and public health, 2022-10, Vol.19 (20), p.13480

2022

Volltextzugriff (PDF)

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Blood, 2023-04, Vol.141 (16), p.1971-1981

2023

Volltextzugriff (PDF)

Prospective Associations between Cumulative Average Intake of Flavonoids and Hypertension Risk in the CArdioVascular Disease Association Study (CAVAS)

Nutrients, 2023-02, Vol.15 (5), p.1186

2023

Volltextzugriff (PDF)

Impact of Types of Breathing on Static Balance Ability in Healthy Adults

International journal of environmental research and public health, 2022-01, Vol.19 (3), p.1205

2022

Volltextzugriff (PDF)

Thermotherapy Plus Neck Stabilization Exercise for Chronic Nonspecific Neck Pain in Elderly: A Single-Blinded Randomized Controlled Trial

International journal of environmental research and public health, 2020-08, Vol.17 (15), p.5572

2020

Volltextzugriff (PDF)

The effects of erythropoiesis‐stimulating agents on the management of chemotherapy‐induced anemia and tumor growth in diffuse large B‐cell lymphoma patients

International journal of cancer, 2019-11, Vol.145 (9), p.2459-2467

2019

Volltextzugriff (PDF)

Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial

Nature communications, 2024-03, Vol.15 (1), p.2776-2776, Article 2776

2024

Volltextzugriff (PDF)

Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma

BMC cancer, 2019-11, Vol.19 (1), p.1080-7, Article 1080

2019

Volltextzugriff (PDF)

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)

American journal of hematology, 2020-04, Vol.95 (4), p.413-421

2020

Volltextzugriff (PDF)

Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma

International journal of hematology, 2023-02, Vol.117 (2), p.225-235

2023

Volltextzugriff (PDF)

Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma

Cancer science, 2012-03, Vol.103 (3), p.477-482

2012

Volltextzugriff (PDF)

Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival

Leukemia, 2019-12, Vol.33 (12), p.2912-2923

2019

Volltextzugriff (PDF)

Effects of Forest Healing Anti-Aging Program on Psychological, Physiological, and Physical Health of Older People with Mild Cognitive Impairment

International journal of environmental research and public health, 2022-04, Vol.19 (8), p.4863

2022

Volltextzugriff (PDF)

Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era

Scientific reports, 2020-07, Vol.10 (1), p.11649, Article 11649

2020

Volltextzugriff (PDF)

Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk

Journal of hematology and oncology, 2020-08, Vol.13 (1), p.115-115, Article 115

2020

Volltextzugriff (PDF)

Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy

American journal of hematology, 2017-12, Vol.92 (12), p.1280-1286

2017

Volltextzugriff (PDF)

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

International journal of hematology, 2021, Vol.113 (1), p.81-91

2021

Volltextzugriff (PDF)

Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma

Bone marrow transplantation (Basingstoke), 2019-12, Vol.54 (12), p.2051-2059

2019

Volltextzugriff (PDF)

1 – 25 von 547

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(516)
Mit Volltextzugriff
(485)

Publikationsform

Artikel
(544)
Tagungsberichte
(3)

Sprache

Englisch
(545)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(543)
EZB Electronic Journals Library
(303)
Ingenta
(276)
Journals@OVID
(177)
IngentaConnect Journals
(148)
Elsevier ScienceDirect Journals Complete
(106)
Springer Journals
(81)
Publisher or Other Site
(75)
EZB-NALI5-00465 Elsevier Archive NL
(74)
Wiley-Blackwell Journals
(64)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(55)
Wiley Online Library
(47)
Nature
(20)
Oxford Journals
(18)
Oxford Journals 2020 Medicine
(13)
Access via Taylor & Francis
(11)
Taylor & Francis Online
(10)
Taylor & Francis
(10)
SAGE Publications
(8)
Nexis Uni
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

The effect of types of sensory feedback on the acquisition and retention of squat performance: A randomized, double‐blind, controlled trial

Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma

The impact of smartphone use on gait in young adults: Cognitive load vs posture of texting

Safety, pharmacokinetics, and pharmacodynamics of a next‐generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients

BAY 94‐9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results

Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)

Influence of Loads and Loading Position on the Muscle Activity of the Trunk and Lower Extremity during Squat Exercise

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Prospective Associations between Cumulative Average Intake of Flavonoids and Hypertension Risk in the CArdioVascular Disease Association Study (CAVAS)

Impact of Types of Breathing on Static Balance Ability in Healthy Adults

Thermotherapy Plus Neck Stabilization Exercise for Chronic Nonspecific Neck Pain in Elderly: A Single-Blinded Randomized Controlled Trial

The effects of erythropoiesis‐stimulating agents on the management of chemotherapy‐induced anemia and tumor growth in diffuse large B‐cell lymphoma patients

Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial

Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)

Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma

Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma

Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival

Effects of Forest Healing Anti-Aging Program on Psychological, Physiological, and Physical Health of Older People with Mild Cognitive Impairment

Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era

Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk

Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma

Aktive Filter

Suchergebnisse filtern